Detalhe da pesquisa
1.
Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Mol Cell Proteomics
; 21(2): 100182, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922008
2.
Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus -independent host genes, via mechanisms of slow replication versus polymorphisms in dsRNA binding σ3 respectively.
PLoS Pathog
; 16(9): e1008803, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32956403
3.
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.
Chem Rev
; 119(2): 797-828, 2019 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295467
4.
Improving MHC-I Ligand Identifications from LC-MS/MS Data by Incorporating Allelic Peptide Motifs.
Proteomics
; 19(5): e1800458, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710433
5.
Therapy-Induced MHC I Ligands Shape Neo-Antitumor CD8 T Cell Responses during Oncolytic Virus-Based Cancer Immunotherapy.
J Proteome Res
; 18(6): 2666-2675, 2019 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31095916
6.
Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.
Anal Chem
; 91(8): 5106-5115, 2019 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30779550
7.
RTN4 Knockdown Dysregulates the AKT Pathway, Destabilizes the Cytoskeleton, and Enhances Paclitaxel-Induced Cytotoxicity in Cancers.
Mol Ther
; 26(8): 2019-2033, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078441
8.
MHC-I Ligand Discovery Using Targeted Database Searches of Mass Spectrometry Data: Implications for T-Cell Immunotherapies.
J Proteome Res
; 16(4): 1806-1816, 2017 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28244318
9.
Quantitative Temporal in Vivo Proteomics Deciphers the Transition of Virus-Driven Myeloid Cells into M2 Macrophages.
J Proteome Res
; 16(9): 3391-3406, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28768414
10.
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy.
Nat Protoc
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769145
11.
Genome-guided discovery of cancer therapeutic targets.
Cell Rep
; 42(8): 112978, 2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572322
12.
A genetic basis for cancer sex differences revealed in Xp11 translocation renal cell carcinoma.
bioRxiv
; 2023 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37577497
13.
How splicing confers treatment resistance in prostate cancer.
Elife
; 112022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998026
14.
Photodynamic therapy of melanoma with new, structurally similar, NIR-absorbing ruthenium (II) complexes promotes tumor growth control via distinct hallmarks of immunogenic cell death.
Am J Cancer Res
; 12(1): 210-228, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35141014
15.
After virus exposure, early bystander naïve CD8 T cell activation relies on NAD+ salvage metabolism.
Front Immunol
; 13: 1047661, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36818473
16.
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma.
Mol Ther Oncolytics
; 24: 695-706, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284625
17.
Improving MHC-I Ligand Identification by Incorporating Targeted Searches of Mass Spectrometry Data.
Methods Mol Biol
; 2120: 161-171, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124318
18.
Cytokines in oncolytic virotherapy.
Cytokine Growth Factor Rev
; 56: 4-27, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33183957
19.
Discovery of immunogenic cell death-inducing ruthenium-based photosensitizers for anticancer photodynamic therapy.
Oncoimmunology
; 10(1): 1863626, 2020 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33457082
20.
ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells.
Cell Death Differ
; 27(1): 363-378, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31197235